Geographic atrophy (GA) is an advanced form of age-related macular degeneration that can lead to progressive and irreversible vision loss. One cause of GA may be the overactivation of the immune cells in the eye. This causes the death of healthy light sensitive cells (photoreceptors) in the macula, the part of the retina that is responsible for central vision and color perception. As the disease progresses and more cells are damaged, the patient's vision may decline.
Geographic was previously untreatable as no known drugs or medications were available for this disease. However, a new form of treatment, an injection called Syfovre, has recently gained FDA approval. Click below to learn more about it:
Remember, each insurance plan has differing policies regarding payment and reimbursement. Contact your insurance company directly to get the most up-to-date information on Syfovre.